West Pharmaceutical Services PE Ratio 2006-2021 | WST

Current and historical p/e ratio for West Pharmaceutical Services (WST) from 2006 to 2021. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. West Pharmaceutical Services PE ratio as of June 11, 2021 is 59.38.

Please refer to the Stock Price Adjustment Guide for more information on our historical prices.

West Pharmaceutical Services PE Ratio Historical Data
Date Stock Price TTM Net EPS PE Ratio
2021-06-11 345.33 61.89
2021-03-31 281.63 $5.58 50.47
2020-12-31 283.00 $4.58 61.79
2020-09-30 274.44 $4.13 66.45
2020-06-30 226.65 $3.79 59.80
2020-03-31 151.75 $3.46 43.86
2019-12-31 149.69 $3.20 46.78
2019-09-30 141.05 $3.05 46.25
2019-06-30 124.32 $3.03 41.03
2019-03-31 109.33 $2.90 37.70
2018-12-31 97.11 $2.75 35.31
2018-09-30 122.15 $2.06 59.30
2018-06-30 98.09 $2.00 49.05
2018-03-31 87.09 $1.76 49.48
2017-12-31 97.19 $1.99 48.84
2017-09-30 94.68 $2.51 37.72
2017-06-30 92.84 $2.34 39.67
2017-03-31 80.03 $2.43 32.93
2016-12-31 83.06 $1.92 43.26
2016-09-30 72.81 $1.85 39.36
2016-06-30 74.05 $1.37 54.05
2016-03-31 67.53 $1.15 58.72
2015-12-31 58.54 $1.30 45.03
2015-09-30 52.50 $1.28 41.02
2015-06-30 56.24 $1.69 33.28
2015-03-31 58.19 $1.83 31.80
2014-12-31 51.34 $1.76 29.17
2014-09-30 43.06 $1.66 25.94
2014-06-30 40.48 $1.60 25.30
2014-03-31 42.18 $1.51 27.93
2013-12-31 46.88 $1.58 29.67
2013-09-30 39.23 $1.55 25.31
2013-06-30 33.41 $1.40 23.95
2013-03-31 30.79 $1.19 25.87
2012-12-31 25.87 $1.15 22.59
2012-09-30 24.98 $1.12 22.41
2012-06-30 23.69 $1.15 20.69
2012-03-31 19.86 $1.21 16.48
2011-12-31 17.64 $1.08 16.33
2011-09-30 17.16 $0.90 19.07
2011-06-30 20.17 $0.91 22.16
2011-03-31 20.55 $0.94 21.98
2010-12-31 18.84 $0.94 20.04
2010-09-30 15.61 $1.15 13.64
2010-06-30 16.53 $1.14 14.50
2010-03-31 18.93 $1.12 16.98
2009-12-31 17.62 $1.06 16.62
2009-09-30 18.18 $1.03 17.74
2009-06-30 15.53 $0.98 15.93
2009-03-31 14.56 $1.10 13.24
2008-12-31 16.69 $1.25 13.35
2008-09-30 21.49 $1.09 19.81
2008-06-30 18.99 $1.07 17.83
2008-03-31 19.35 $1.02 18.97
2007-12-31 17.70 $1.03 17.26
2007-09-30 18.10 $1.15 15.74
2007-06-30 20.43 $1.17 17.54
2007-03-31 20.06 $1.11 18.08
2006-12-31 22.08 $1.00 22.08
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $25.379B $2.147B
West Pharmaceutical Services, Inc. is a global drug delivery technology company that applies proprietary materials science, formulation research and manufacturing innovation to advance the quality, therapeutic value, development speed and rapid market availability of pharmaceuticals, biologics, vaccines and consumer healthcare products. West is the world's premiere provider of standard-setting systems and device components for parenterally administered medicines and an emerging leader in the development of advanced formulation technologies for the transmucosal delivery of drugs. West contract manufacturing harnesses a powerful combination of innovation, technology, infrastructure and expertise to serve the pharmaceutical, medical and consumer industries. Along with more than 50 years of experience, they bring customers quality, safety and reliability in injection molding, contract assembly and finished packaging.
Stock Name Country Market Cap PE Ratio
Becton Dickinson (BDX) United States $71.370B 19.28
Align Technology (ALGN) United States $48.443B 106.46
McKesson (MCK) United States $30.927B 11.35
Laboratory Of America Holdings (LH) United States $25.501B 8.61
AmerisourceBergen (ABC) United States $24.842B 14.31
Straumann Holding AG (SAUHF) Switzerland $23.596B 0.00
Cooper (COO) United States $18.425B 31.20
Cardinal Health (CAH) United States $17.412B 10.31
DENTSPLY SIRONA (XRAY) United States $14.424B 31.76
Henry Schein (HSIC) United States $11.056B 24.03
STAAR Surgical (STAA) United States $6.764B 327.80
CONMED (CNMD) United States $3.964B 59.76
SmileDirectClub (SDC) United States $3.774B 0.00
Patterson (PDCO) United States $3.475B 18.25
Merit Medical Systems (MMSI) United States $3.438B 34.30
Atrion (ATRI) United States $1.142B 37.05
Antares Pharma (ATRS) United States $0.746B 49.11
Retractable Technologies (RVP) United States $0.382B 8.58
Invacare (IVC) United States $0.290B 0.00
Milestone Scientific (MLSS) United States $0.146B 0.00
Pro-Dex (PDEX) United States $0.120B 30.28
Lifevantage (LFVN) United States $0.118B 8.63
Biolase (BIOL) United States $0.112B 0.00